SRP5038
HGK (1-328), active, GST tagged human
PRECISIO® Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution
Synonyme(s) :
FLH21957, FLJ10410, FLJ20373, FLJ90111, KIAA0687, MAP4K4, NIK
Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
About This Item
Code UNSPSC :
12352202
Nomenclature NACRES :
NA.32
Produit recombinant
expressed in baculovirus infected Sf9 cells
Gamme de produits
PRECISIO® Kinase
Pureté
≥70% (SDS-PAGE)
Forme
buffered aqueous glycerol solution
Activité spécifique
46-62 nmol/min·mg
Poids mol.
~64 kDa
Numéro d'accès NCBI
Conditions d'expédition
dry ice
Température de stockage
−70°C
Informations sur le gène
human ... MAP4K4(9448)
Description générale
Hepatocyte progenitor kinase-like/germinal center kinase-like kinase (HGK) i or mitogen-activated protein kinase kinase kinase kinase 4(MAP4K4) is a member of the serine/threonine protein kinase family. HGK has been shown to specifically activate MAPK8/JNK. The activation of MAPK8 by HGK can be inhibited by dominant-negative mutants of MAP3K7(mitogen-activated protein kinase kinase kinase 7)/TAK1(transforming growth factor β-activated kinase 1), MAP2K4/MKK4 (mitogen-activated protein kinase kinase 4), and MAP2K7/MKK7, which suggest that this kinase functions through the MAP3K7-MAP2K4-MAP2K7 kinase cascade and mediates TNF-α signaling. HGK-dependent signaling inhibits peroxisome proliferator-activated receptor γ(PPARγ)-responsive gene expression, adipogenesis, and insulin-stimulated glucose transport. MAP4K4 gene is mapped to human chromosome 2q11.2.
Actions biochimiques/physiologiques
Mitogen-activated protein kinase kinase kinase kinase 4(MAP4K4) enzyme participates in promoting and suppressing inflammatory process. The MAP4K4 gene is upregulated in adenocarcinoma. Map4k4 in mice, is necessary for normal lymphatic vascular function. From endothelium-specific Map4k4 knockout models, it is found that atherosclerosis and lymphocyte recruitment might be induced by Map4k4. MAP4K4 is known to cause insulin resistance which is associated with Type 2 diabetes mellitus pathogenesis. It mediates tumor necrosis factor-α induced β cells necrosis.
Forme physique
Supplied in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol.
Notes préparatoires
after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles
Informations légales
PRECISIO is a registered trademark of Merck KGaA, Darmstadt, Germany
Code de la classe de stockage
10 - Combustible liquids
Classe de danger pour l'eau (WGK)
WGK 1
Certificats d'analyse (COA)
Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
MAP 4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance.
Gao X, et al.
Molecular Oncology, 11(6), 628-639 (2017)
Association of common genetic variants in mitogen-activated protein kinase kinase kinase kinase 4 with type 2 diabetes mellitus in a Chinese Han population.
Li T T, et al.
Chinese Medical Journal (English Edition), 129(10), 1179-1179 (2016)
A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway.
Yao Z, et al.
The Journal of Biological Chemistry, 274(4), 2118-2125 (1999)
Endothelial MAP4K4 is critical for lymphatic vascular development and function.
Flach R J R, et al.
Molecular and Cellular Biology (2016)
Xiaoqing Tang et al.
Proceedings of the National Academy of Sciences of the United States of America, 103(7), 2087-2092 (2006-02-08)
The insulin-regulated glucose transporter GLUT4 is a key modulator of whole body glucose homeostasis, and its selective loss in adipose tissue or skeletal muscle causes insulin resistance and diabetes. Here we report an RNA interference-based screen of protein kinases expressed
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique